West End Services, Inc. (Christopher Leon, owner)
Outcome
West End Services and owner Christopher Leon settled for $825,000 for billing Medicare for high-cost prescription drugs including Latuda, Humira, Abilify, Invega Sustenna, and Truvada that were never actually dispensed to beneficiaries.
Details
West End Services, Inc. / Christopher Leon (Allentown, PA) — Medicare Pharmacy Fraud
Outcome: Settled for $825,000 for billing Medicare for high-cost specialty drugs never dispensed to beneficiaries; settlement based on ability to pay.
West End Services, Inc., an Allentown area pharmacy owned by pharmacist Christopher Leon, submitted false claims to Medicare from January 1, 2014 through February 24, 2019 for prescription medications that were never actually dispensed to Medicare beneficiaries. The drugs fraudulently billed included high-cost specialty and branded medications: Latuda, Humira, Abilify, Invega Sustenna, Seroquel, Acyclovir, Flovent, and Truvada.
The billing of these high-cost specialty drugs without dispensing them represents a particularly lucrative fraud category — drugs like Humira (rheumatoid arthritis), Invega Sustenna (long-acting antipsychotic), and Truvada (HIV PrEP) command premium reimbursement rates that far exceed typical generic medications.
The U.S. Attorney's Office for the Eastern District of Pennsylvania announced the $825,000 settlement on August 8, 2025, with the settlement amount noted as based on ability to pay.
Primary Source: Allentown-Area Pharmacy and Its Owner Agree to Pay $825,000 to Resolve Allegations of False Claims Act Liability
How Crucible Prevents This
Crucible's high-cost drug reconciliation controls would flag billing for specialty medications like Humira and Invega Sustenna without corresponding purchase invoices; a compliance gate comparing specialty drug procurement records against claim submissions would surface undispensed high-cost drug billing immediately.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works